David Lebowitz

Stock Analyst at Citigroup

(2.02)
# 1,549
Out of 4,442 analysts
71
Total ratings
38.89%
Success rate
-6.96%
Average return

21 Stocks

PTC Therapeutics
May 21, 2024
Maintains: Sell
Price Target: $18$26
Current: $37.20
Upside: -30.11%
Intellia Therapeutics
May 10, 2024
Maintains: Neutral
Price Target: $31$29
Current: $24.84
Upside: +16.75%
Pliant Therapeutics
May 7, 2024
Maintains: Buy
Price Target: $45$44
Current: $12.73
Upside: +245.64%
Blueprint Medicines
May 3, 2024
Maintains: Sell
Price Target: $65$76
Current: $102.81
Upside: -26.08%
Schrödinger
May 2, 2024
Maintains: Buy
Price Target: $39$37
Current: $21.98
Upside: +68.33%
Madrigal Pharmaceuticals
Mar 6, 2024
Initiates: Buy
Price Target: $382
Current: $229.58
Upside: +66.39%
Cogent Biosciences
Feb 26, 2024
Maintains: Buy
Price Target: $11$13
Current: $8.22
Upside: +58.15%
BridgeBio Pharma
Feb 23, 2024
Maintains: Buy
Price Target: $42$46
Current: $27.94
Upside: +64.64%
Incyte
Feb 14, 2024
Maintains: Buy
Price Target: $82$81
Current: $57.31
Upside: +41.34%
Ascendis Pharma
Feb 8, 2024
Maintains: Buy
Price Target: $146$182
Current: $130.41
Upside: +39.56%
Exelixis
Dec 15, 2023
Initiates: Buy
Price Target: $31
Current: $20.57
Upside: +50.70%
Ionis Pharmaceuticals
Jul 31, 2023
Upgrades: Buy
Price Target: $36$60
Current: $37.28
Upside: +60.94%
BioMarin Pharmaceutical
Jun 30, 2023
Maintains: Neutral
Price Target: $103$96
Current: $75.52
Upside: +27.12%
Mirum Pharmaceuticals
Nov 10, 2022
Maintains: Buy
Price Target: $38$34
Current: $24.55
Upside: +38.49%
Immuneering
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $18$12
Current: $1.39
Upside: +763.31%
Alnylam Pharmaceuticals
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $170$164
Current: $147.76
Upside: +10.99%
Arcutis Biotherapeutics
Jun 7, 2022
Maintains: Overweight
Price Target: $36$39
Current: $9.16
Upside: +325.76%
Syndax Pharmaceuticals
Oct 12, 2021
Maintains: Equal-Weight
Price Target: n/a
Current: $20.28
Upside: -
Karyopharm Therapeutics
Oct 12, 2021
Maintains: Overweight
Price Target: n/a
Current: $1.05
Upside: -
Ironwood Pharmaceuticals
Oct 12, 2021
Maintains: Equal-Weight
Price Target: n/a
Current: $5.95
Upside: -
AVROBIO
Oct 12, 2021
Maintains: Overweight
Price Target: n/a
Current: $1.51
Upside: -